Author pages are created from data sourced from our academic publisher partnerships and public sources.
Yttrium-90 Radioembolization for Unresectable, Chemoresistant Breast Cancer Liver Metastases: A Large Single-Center Experience of 40 Patients
- BMedSc Akshat Saxena MBBS, BMedSc Jada Kapoor MBBS, PhD Baerbel Meteling BVetMed, MD PhD David L. Morris MBBS, BSc Lourens Bester MBChB
- Annals of Surgical Oncology
There are a paucity of data on the treatment of unresectable, chemoresistant breast cancer liver metastases (BRCLM) with yttrium-90 (Y90) radioembolization. Forty patients underwent resin-based Y90… Expand